Skip to main content
. 2019 May 9;352(6):1800330. doi: 10.1002/ardp.201800330

Table 1.

Activity in human coronavirus 229E‐infected HEL a cells

Compounds Antiviral activity (EC50 b ) Cytotoxicity (MCC c )
7a >100 >100
7b >100 >100
7c >100 >100
7d >100 ≥100
7e >100 >100
7f >100 >100
7g >100 >100
7h >100 >100
7i >100 >100
7j >100 >100
7k >100 >100
7l >100 >100
7m 31 ± 1 >100
7n 12 ± 1 100
8a >100 >100
8b >100 >100
8c >100 >100
8d >100 >100
8e >100 >100
8f >100 >100
8g >100 >100
8h >100 100
8i >100 >100
8j >100 >100
8k 28 ± 0 >100
8l 18 ± 5 ≥100
8m 8.1 ± 2.2 100
8n 5.5 ± 0.7 ≥100
8o >100 >100
8p 6.1 ± 0.2 50
K22 3.3 ± 1.0 50

Data represent the averages ± SEM of 3–4 independent tests.

a

HEL: human embryonic lung fibroblast cells.

b

EC50: compound concentration (µM) producing 50% inhibition of virus replication, as determined by microscopic scoring of the cytopathic effect (CPE).

c

MCC: minimum cytotoxic concentration (µM), that is, compound concentration producing minimal changes in cell morphology, as estimated by microscopy.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.